Search research articles
Contact Us
Filters
Showing results (171-180 of 206) with videos related to
Page
of 21
Sort By:
Carcinogenesis
|
July 7, 2016
Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients
Francesco Sclafani, Ian Chau, David Cunningham, et al.
International Journal of Colorectal Disease
|
May 9, 2020
The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference
Michela Roberto, Paolo Marchetti, Giulia Arrivi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 9, 2015
A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer
Filippo Pietrantonio, Giuseppe Aprile, Lorenza Rimassa, et al.
British Journal of Cancer
|
November 2, 2016
MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma
Francesco Trevisani, Michele Ghidini, Alessandro Larcher, et al.
Mucosal Immunology
|
April 2, 2023
iNKT cell-neutrophil crosstalk promotes colorectal cancer pathogenesis
Georgia Lattanzi, Francesco Strati, Angélica Díaz-Basabe, et al.
Cancers
|
September 3, 2020
Evaluation of Prognostic Factors for Survival in Transverse Colon Cancer
Michela Roberto, Giulia Arrivi, Francesca Lo Bianco, et al.
The Oncologist
|
November 26, 2024
Changes in clinical presentation, management, and survival outcomes in patients affected by colorectal cancer following COVID-19 pandemic
Alessandro Parisi, Riccardo Giampieri, Silvia Villani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2024
Circulating Tumor DNA Dynamics and Clinical Outcome in Metastatic Colorectal Cancer Patients Undergoing Front-Line Chemotherapy
Michele Ghidini, Jens Claus Hahne, Chiara Senti, et al.
Frontiers in Oncology
|
November 15, 2021
Post-Induction Management in Patients With Left-Sided <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study
Alessandro Parisi, Alessio Cortellini, Olga Venditti, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 15, 2021
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?
Paolo Antonetti, Maria Concetta Fargnoli, Giampiero Porzio, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 206) with videos related to
Sort By:
Page
of 21
Carcinogenesis
|
July 7, 2016
Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients
Francesco Sclafani, Ian Chau, David Cunningham, et al.
International Journal of Colorectal Disease
|
May 9, 2020
The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference
Michela Roberto, Paolo Marchetti, Giulia Arrivi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 9, 2015
A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer
Filippo Pietrantonio, Giuseppe Aprile, Lorenza Rimassa, et al.
British Journal of Cancer
|
November 2, 2016
MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma
Francesco Trevisani, Michele Ghidini, Alessandro Larcher, et al.
Mucosal Immunology
|
April 2, 2023
iNKT cell-neutrophil crosstalk promotes colorectal cancer pathogenesis
Georgia Lattanzi, Francesco Strati, Angélica Díaz-Basabe, et al.
Cancers
|
September 3, 2020
Evaluation of Prognostic Factors for Survival in Transverse Colon Cancer
Michela Roberto, Giulia Arrivi, Francesca Lo Bianco, et al.
The Oncologist
|
November 26, 2024
Changes in clinical presentation, management, and survival outcomes in patients affected by colorectal cancer following COVID-19 pandemic
Alessandro Parisi, Riccardo Giampieri, Silvia Villani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2024
Circulating Tumor DNA Dynamics and Clinical Outcome in Metastatic Colorectal Cancer Patients Undergoing Front-Line Chemotherapy
Michele Ghidini, Jens Claus Hahne, Chiara Senti, et al.
Frontiers in Oncology
|
November 15, 2021
Post-Induction Management in Patients With Left-Sided <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study
Alessandro Parisi, Alessio Cortellini, Olga Venditti, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 15, 2021
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?
Paolo Antonetti, Maria Concetta Fargnoli, Giampiero Porzio, et al.
Page
of 21